Development and characterization of a monoclonal antibody blocking human TRPM4 channel

See Wee Low(National Neuroscience Institute), Ping Liao(Singapore Institute of Technology)

Scientific Reports

May 17, 2021

10.1038/s41598-021-89935-5

Cited by 15

Related Papers

Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia

|Frontiers in Cell and Developmental Biology|2020|33

Enhanced isradipine sensitivity in vascular smooth muscle cells due to hypoxia‐induced Ca<sub>v</sub>1.2 splicing and <scp>RbFox1</scp>/Fox2 downregulation

|FEBS Journal|2024|5

<i>In vivo</i> evaluation of monoclonal antibody M4M using a humanised rat model of stroke demonstrates attenuation of reperfusion injury via blocking human TRPM4 channel

|Journal of drug targeting|2024|4